The EU Commission conditionally approves a merger in the pharmaceutical sector leading to the creation of the world’s largest pharmaceuticals company (Glaxo Wellcome / SmithKline Beecham)

"Merger Control: main developments between 1st May 2000 and 31st August 2000"* Resulting from the merger between Glaxo Wellcome and SmithKline Beecham, the new company, Glaxo SmithKline, will be the world’s biggest pharmaceuticals firm with 7.3% of global sales. The deal raised concerns

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • European External Action Service (Brussels)
  • Financial Conduct Authority (London)
  • DG COMP (Brussels)

Quotation

Walter Tretton, Neil Marshall, Anna Papaioannou, The EU Commission conditionally approves a merger in the pharmaceutical sector leading to the creation of the world’s largest pharmaceuticals company (Glaxo Wellcome / SmithKline Beecham), 8 May 2000, e-Competitions Bulletin May 2000, Art. N° 39148

Visites 233

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues